Insider holders · CIK 0001411879
INNOVUS PHARMACEUTICALS, INC. · INNV
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Novalere Holdings, LLC10% Owner | 25,617,592 | — | 25,617,592 | Dec 2, 2016 · 6:18 pm EST | Form 4 |
| Bassam DamajPRESIDENT AND CEO | 6,852,322 | — | 6,852,322 | Jun 29, 2015 · 4:48 pm EDT | Form 4 |
| Vivian H LiuDirector | 901,219 | — | 901,219 | Jan 6, 2015 · 4:48 pm EST | Form 4 |
| Ziad MirzaDirector | 474,483 | — | 474,483 | Jan 6, 2015 · 4:52 pm EST | Form 4 |
| Robert HoffmanChief Financial Officer | 280,103 | — | 280,103 | Sep 7, 2016 · 4:25 pm EDT | Form 3 |
| Henry Jemil EsberDirector | 100,000 | — | 100,000 | Nov 27, 2017 · 7:45 pm EST | Form 4 |
| Randy BerholtzEVP, CORPORATE DEVELOPMENT | 16,880 | — | 16,880 | Nov 27, 2017 · 7:45 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.